Abstract: According to one embodiment, a memory device includes a stacked structure including a plurality of conductive layers stacked to be apart from each other in a first direction, and a pillar structure including a resistance change portion extending in the first direction in the stacked structure, and a semiconductor portion which extends in the first direction in the stacked structure and which includes a first portion provided along the resistance change portion and a second portion extending from the first portion in at least one direction intersecting the first direction.

Abstract: The present invention provides an agrochemically active microbial formulation comprising a combination of an agrochemically active microbe with a specified ester compound and a surfactant, the formulation exhibiting a stable pest controlling effect with no harmful effect on a plant and having highly stable viability of the agrochemically active microbe.

Abstract: The present invention provides an agrochemically active microbial formulation comprising a combination of an agrochemically active microbe with a specified ester compound and a surfactant, the formulation exhibiting a stable pest controlling effect with no harmful effect on a plant and having highly stable viability of the agrochemically active microbe

Abstract: The present invention provides an insecticidal oil-based formulation, which comprises a petroleum hydrocarbon oil, a nonionic surfactant suitable for emulsifying the petroleum hydrocarbon oil, a desiccating agent and an insecticidal filamentous fungus; and a method for controlling insect pests, which comprises applying said formulation to an insect pests, a habitat of the insect pest or a plant vulnerable to the insect pest; and the like.

Abstract: The present invention provides a novel gene encoding a protein having an excellent catalyst ability for producing (S)-N-substituted cyclic imino acid represented by the general formula (2) (=the (S)-cyclic imino acid (2)): and to provide a novel method for producing the (S)-cyclic imino acid (2) by an asymmetric hydrolization of the N-substituted cyclic imino acid ester represented by the general formula (1): in a manner of gene engineering technology utilizing the novel gene provided.

Abstract: The present invention provides a novel gene encoding a protein having an excellent catalyst ability for producing (S)-N-substituted cyclic imino acid represented by the general formula (2) (=the (S)-cyclic imino acid (2)): and to provide a novel method for producing the (S)-cyclic imino acid (2) by an asymmetric hydrolization of the N-substituted cyclic imino acid ester represented by the general formula (1): in a manner of gene engineering technology utilizing the novel gene provided.

Abstract: A method for producing from one of the optical isomers (optical isomer I) of an amino acid represented by Formula (1):R—CH(NH2)—COOH (1), wherein R is defined in the specification, the other of the optical isomers (optical isomer II), said method comprising reacting a biological material which has an ability of converting said one of the optical isomers (optical isomer I) to said the other of the optical isomers (optical isomer II), the isomerism being on the basis of an assymetric carbon atom to which both of an amino group and a carboxyl group are bound and said ability being not inhibited seriously by an amino acid transferase inhibitor &bgr;-chloro-D-alanine, &bgr;-chloro-L-alanine or gabaculine, with said one of the optical isomers (optical isomer I).

Abstract: DNA encoding a novel protein from Mycobacterium aurum SC-S423 capable of converting acetophenone to an optically active 1-phenylethlamine in the presence of a racemic mixture of sec-butylamine is provided, along with a vector and host cell comprising the same and a method of producing the same.

Abstract: The present invention provides a novel gene encoding a protein having an excellent catalyst ability for producing (S)-N-substituted cyclic imino acid represented by formula (2): and provides a novel method for producing (S)-N-substituted cyclic imino acid represented by formula (2) by an asymmetric hydrolization of the N-substituted cyclic imino acid ester represented by formula (1): in a manner of gene engineering technology utilizing the novel gene provided.

Abstract: A method for producing from one of the optical isomers (optical isomer I) of an amino acid represented by Formula (1):R—CH(NH2)—COOH (1), wherein R is defined in the specification, the other of the optical isomers (optical isomer II), said method comprising reacting a biological material which has an ability of converting said one of the optical isomers (optical isomer I) to said the other of the optical isomers (optical isomer II), the isomerism being on the basis of an assymetric carbon atom to which both of an amino group and a carboxyl group are bound and said ability being not inhibited seriously by an amino acid transferase inhibitor &bgr;-chloro-D-alanine, &bgr;-chloro-L-alanine or gabaculine, with said one of the optical isomers (optical isomer I).

Abstract: The present invention provides a novel gene encoding a protein having an excellent catalyst ability for producing (S)-N-substituted cyclic imino acid represented by the general formula (2) (=the (S)-cyclic imino acid (2)): 1

Abstract: The present invention provides a novel gene encoding a protein having an excellent catalyst ability for producing (S)-N-substituted cyclic imino acid represented by the general formula (2) (=the (S)-cyclic imino acid (2)): 1

Abstract: According to the present invention, a novel protein capable of catalyzing transamination stereoselectively and a gene encoding said protein can be provided.

Abstract: A novel protein from Mycobacterium aurum SC-D423 capable of converting acetophenone to an optically active 1-phenylethylamine in the presence of a racemic mixture of sec-butylamine is provided.

Abstract: There is disclosed a method of resolving 2-oxobicyclo[3.1.0]hexane-6-carboxylates having the following relative configuration of formula (1): wherein X1, X2, R1, R2 and R3 have the same meanings as defined below, into one enantiomer ester thereof and the other enantiomer acid, which is characterized by contacting an enzyme having an ability to preferentially hydrolyze one enantiomer ester contained in 2-oxobicyclo[3.1.0]hexane-6-carboxylate of formula (1) as defined above, with 2-oxobicyclo[3.1.0]hexane-6-carboxylates of formula (1) as defined above to obtain one enantiomer as an acid and the other enantiomer as an ester.

Abstract: The present invention provides a process for producing a carboxylic acid isomer B represented by the general formula (2): (wherein, L is a C6 to C14 aryl group which may optionally been substituted, C4 to C12 heteroaryl group which may optionally been substituted, C6 to C14 aryloxy group which may optionally been substituted or C4 to C12 heteroaryloxy group which may optionally been substituted, and M is an C1 to C3 alkyl group.), which comprises: allowing a carboxylic acid isomer A represented by the general formula (1):  (wherein, L and M have meanings as defined above.) to contact with a microbiological material having an ability to convert the carboxylic acid isomer A(1) into the carboxylic acid isomer B(2), and the like. According to the present invention, the carboxylic acid isomer B(2) useful as an intermediate of medicines, agricultural chemicals and like can be produced efficiently.

Abstract: There is provided a process for producing an optically active N-substituted azetidine-2-carboxylic acid compound represented by the formula (2): ##STR1## by contacting a corresponding N-substituted azetidine-2-carboxylic acid ester of formula (2) with an enzyme derived from a microorganism selected from Arthrobacter SC-6-98-28 strain, Arthrobacter sp. ATCC21908 strain, Chromobacterium SC-YM-1 strain, and a mutant thereof. A process is also provided for preparing an optically active azetidine-2-carboxylic acid by eliminating the N-substituent of a N-substituted azetidine-2-carboxylic acid ester of formula (2).

Abstract: The present invention provides a process for production of amide compounds, which includes converting a nitrile compound into its corresponding amide compound by hydrating the nitrile compound in the presence of a cultured broth of bacterial cells, intact bacterial cells, disrupted bacterial cells or enzymes contained therein, or immobilized preparations obtainable by immobilizing intact bacterial cells, disrupted bacterial cells or enzymes contained therein, the bacterial cells being those of a biologically pure culture of a thermophilic microorganism having hydration activity to convert a nitrile compound into its corresponding amide compound, such as Bacillus smithii SC-J05-1 (FERM BP-4935).

Abstract: There is disclosed a process for production of amide compounds which includes converting a nitrile compound into an amide compound using a cultured broth of bacterial cells, or bacterial cells or materials obtainable by treating bacterial cells, the bacterial cells being cells of a microorganism Agrobacterium radiobacter FERM BP-3843, having activity to convert nitrile compounds into corresponding amide compounds.